AVE 20.0% 0.3¢ avecho biotechnology limited

esra ogru background, page-66

  1. 34,916 Posts.
    lightbulb Created with Sketch. 480
    Would seem the support continues today Turps. Might we see some more interest in POH if single dose ann comes through and surprises resultswise.

    How would results surprise? I would think the expectation from most would be that results of 'single-dose' trials would be highly successful and mostly factored in already.

    Maybe it would recover lost ground since this debacle was announced but frankly, 13c-15c wasn't where I hoped to be after trial announcement.

    I don't really see a lot of short-term upside unless we can show a decent revenue boost in the next set of financials in around a month or so. Since this will be reporting on end of June figures, not sure based on share price movement that this will be of much interest to most investors meaning another wait of 6 months before next financial results.

    Anyway one can only hope for a change of fortune.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.001(20.0%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $1.366K 455.7K

Buyers (Bids)

No. Vol. Price($)
60 99145902 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 22467224 7
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.